KRO-15338

InChI=1/C3H3BrO2/c4-2-1-3(5)6/h1-2H,(H,5,6)/b2-1; 3t-bromo-acrylic acid; (E)-3-bromoprop-2-enoic acid; (2Z)-3-bromoacrylic acid; 3-bromo-2E-propenoic acid; 2-propenoic acid,3-bromo-,(2Z); (E)-3-Bromopropenoic acid; trans-3-Bromoacrylic acid; 3E-bromoacrylate; (E)-3-bromoacrylic acid

6213-89-4
98% min.
scale-up (10-1,000 kg)
C3H3BrO2

KRO-05316

(3S,5S)-3,5-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-1-hydroxy-cyclohexanecarboxylic Acid Methyl Ester; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone monoethanesulphonate; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone monoethanesulfonate; methyl (3Z)-3-[({4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]phenyl}amino)(phenyl)methylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylate ethanesulfonate salt; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone monoethanesulfonate salt; 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-ethylene]-6-methoxycarbonyl-2-indolinone monoethanesulfonate; methyl (3S,5R)-3,5-di[(tert-butyldimethylsilyl)oxy]-1-hydroxy-cyclohexanecarboxylate; nintedanib ethanesulfonate salt; Ethanesulfonic acid - methyl (3Z)-3-{[(4-{methyl[(4-methyl-1-pipe razinyl)acetyl]amino}phenyl)amino](phenyl)methylene}-2-oxo-6-indo linecarboxylate (1:1); methyl (3S,5S)-3,5-bis[tert-butyl(dimethyl)silyloxy]-1-hydroxy-cyclohexanecarboxylate

656247-18-6
98% min.
scale-up (10-1,000 kg)
C33H39N5O7S

KRO-32540

3-[1-methoxy-1-phenylmeth-(E)-ylidene]-2-oxo-2,3-dihydro-1H-indole-6-carboxylic acid methyl ester

1168150-46-6
98% min.
scale-up (10-1,000 kg)
C18H15NO4

KRO-05317

[14C]-Intedanib; Nintedanib; Intedanib; Imidafenacin; Uritos; Staybla

656247-17-5
98% min.
scale-up (10-1,000 kg)
C31H33N5O4

KRO-13591

N-[(4-methyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-4-nitroaniline; N-(4-nitrophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide; N-methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)-acetamide; QC-1091

1139453-98-7
98% min.
scale-up (10-1,000 kg)
C14H20N4O3

KRO-36468

N-methyl-4-nitro-; .N-bromoacetyl-N-methyl-4-nitro-aniline; .N-(2-bromomethylcarbonyl)-N-methyl-4-nitroaniline; .2-Brom-4''-nitro-N-methylacetanilid

23543-31-9
98% min.
scale-up (10-1,000 kg)
C9H9BrN2O3

KRO-37574

QC-211; N-methyl-4-nitrochloroacetanilide

2653-16-9
98% min.
scale-up (10-1,000 kg)
C9H9ClN2O3

KRO-42914

1,3-dimethyl 2-[4-(methoxycarbonyl)-2-nitrophenyl]propanedioate

1160293-27-5
98% min.
scale-up (10-1,000 kg)
C13H13NO8

KRO-34912

[1,1''-Biphenyl]-3-carboxylic acid,2''-hydroxy-3''-nitro; 2-HYDROXY-3''''-NITRO-BIPHENYL-3-CARBOXYLIC ACID; BIP029; 2-HYDROXY-3A''A inverted exclamation markA''A A''A inverted exclamation markA''A-NITRO-BIPHENYL-3-CARBOXYLIC ACID

376591-95-6
98% min.
scale-up (10-1,000 kg)
C13H9NO5

KRO-29443

1-(3,4-dimethylphenyl)-3-methyl-3-pyrazolin-5-one

18048-64-1
98% min.
scale-up (10-1,000 kg)
C12H14N2O

KRO-35558

[1,1''-Biphenyl]-3-carboxylic acid,2''-methoxy-3''-nitro; BIP028; 2''-methoxy-3''-nitrobiphenyl-3-carboxylic acid

376591-94-5
98% min.
scale-up (10-1,000 kg)
C14H11NO5

KRO-05689

17-hydroxy-19-norpregna-4,9-diene-3,20-dione; 17-Hydroxy-19-nor-pregn-4-en-3,20-dion; 17-hydroxy-19-nor-4-pregnene-3,20-dione; 17-hydroxy-19-norpregn-4-ene-3,20-dione

14340-01-3
98% min.
scale-up (10-1,000 kg)
C20H26O3

KRO-31891

3-(ethylcarbamoyl)phenylboronic acid; 3-(Ethylcarbamoyl)benzeneboronic acid; 3-(N-Ethylaminocarbonyl)benzeneboronic acid; 3-(N-Ethylaminocarbonyl)phenylboronic acid

42982-49-0
98% min.
scale-up (10-1,000 kg)
C22H30O4

KRO-34131

(5a,11b)-11-[4-(Dimethylamino)phenyl]-5,17-dihydroxy-19-norpregn-9-ene-3,20-dionecyclicbis(1,2-ethanediylacetal); (5A,11B)-11-[4-(DIMETHYLAMINO)PHENYL]-5,17-DIHYDROXY-19-NORPREGN-9-ENE-3,20-DIONE CYCLIC BIS(1,2-ETHANEDIYL ACETAL)

126690-41-3
98% min.
scale-up (10-1,000 kg)
C32H45NO6

KRO-49607

6J5J15Q2X8; Ulipristal; Ulipristal (USAN/INN); Deacetyl CDB 2914; Ulipristal,11beta-[4-(N,N-diMethylaMino)-phenyl]-17alpha-hydroxy-19-norpregna-4,9-diene-3,20-dione; Ulipristal [USAN:INN:BAN]

159811-51-5
98% min.
scale-up (10-1,000 kg)
C28H35NO3

KRO-47696

17α-acetoxy-19-norpregna-4,9-diene-3,20-dione

14340-04-6
98% min.
scale-up (10-1,000 kg)
C22H28O4

KRO-31884

cyclic-3-(1,2-ethanediylacetal)-17beta-cyano-17alpha-hydroxy-estra-5(10),9(11)-dien-3-one

33300-19-5
98% min.
scale-up (10-1,000 kg)
C21H27NO3

KRO-20921

5-Chlor-2,3-diphenyl-pyrazin; 2-chloro-4,6-diphenylpyrazine; 2,3-diphenyl-5-chloropyrazine; 5-chloro-2,3-diphenyl-pyrazine; 2-chloro-5,6-diphenylpyrazine

41270-66-0
98% min.
scale-up (10-1,000 kg)
C16H11ClN2

KRO-27338

4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]-1-butanol

475086-75-0
98% min.
scale-up (10-1,000 kg)
C23H27N3O

KRO-41334

4-[[(2S,4R)-5-ethoxy-4-methyl-5-oxo-1-(4-phenylphenyl)pentan-2-yl]amino]-4-oxobutanoic acid; AHU-377; ENTRESTO; 4-(((2S,4R)-1-([1,1''-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid

149709-62-6
98% min.
scale-up (10-1,000 kg)
C24H29NO5